G A Glaubiger - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

G A Glaubiger

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Neurology|December 1, 1975

On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patientsI Shoulson, G A Glaubiger, T N Chase

Lancet (London, England)|June 16, 1973

Sustained-release levodopaA C Woods, G A Glaubiger, T N Chase

Archives of Neurology|May 1, 1974

Parkinson disease treated with a suspected dopamine receptor agonistT N Chase, A C Woods, G A Glaubiger

Clinical Endocrinology|November 1, 1976

Effect of a large dose of thyrotrophin releasing factor on pituitary and thyroid function in patients with ParkinsonismB C Nisula, G A Glaubiger, J P Louvet, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Neurology|December 1, 1975

On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patientsI Shoulson, G A Glaubiger, T N Chase

Lancet (London, England)|June 16, 1973

Sustained-release levodopaA C Woods, G A Glaubiger, T N Chase

Archives of Neurology|May 1, 1974

Parkinson disease treated with a suspected dopamine receptor agonistT N Chase, A C Woods, G A Glaubiger

Clinical Endocrinology|November 1, 1976

Effect of a large dose of thyrotrophin releasing factor on pituitary and thyroid function in patients with ParkinsonismB C Nisula, G A Glaubiger, J P Louvet, et al.

Pageof 1